Royal UNIBREW A/S
COMPANY ANNOUNCEMENT NO 5/2021 – 1 FEBRUARY 2021
On 17 November 2020, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 38/2020 of 17 November 2020. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the Market Abuse Regulation - MAR) and the resulting delegated legislation. The share buy-back program is expected to be realised in the period from 18 November 2020 to 29 January 2021. The total share buy-back in the period will not exceed a market price of DKK 200 million.
The following transactions have been made under the program:
| Number of Shares | Average purchase price | Transaction value, DKK | |
| Accumulated, last announcement | 283,804 | 663.14 | 188,202,397.09 |
| 25 January 2021 | 4,074 | 623.76 | 2,541,196.61 |
| 26 January 2021 | 4,500 | 626.09 | 2,817,420.30 |
| 27 January 2021 | 4,954 | 612.30 | 3,033,309.43 |
| 28 January 2021 | 3,834 | 614.93 | 2,357,636.64 |
| 29 January 2021 | 1,700 | 609.68 | 1,036,455.32 |
| Accumulated under the program | 302,866 | 660.32 | 199,988,415.39 |
Royal Unibrew’s accumulated share buy-back from 18 November 2020 to 29 January 2021 amounts to 302,866 shares at a total cost of DKK 200 million. The announced share buy-back program has thus been completed.
The transactions stated above imply that Royal Unibrew A/S now owns a total of 785.361 treasury shares of a nominal value of DKK 2 each, corresponding to 1,6% of the share capital. The total amount of shares in the company is 49,350,000, including treasury shares.
For further information on this Announcement:
Lars Vestergaard, CFO, tel (+45) 30 93 18 08
www.royalunibrew.com
Attachments
- Fond-RU-5-2021-uk - share buy-back program completed
- Encl. Company Announcement-01022021-PUBLIC_sbb_ROYAL_UNIBREW
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
